$ALXN Headlines Tesla, Facebook, Netflix are M
Post# of 94144
Posted On: 04/10/2014 10:30:10 AM
$ALXN Headlines
Tesla, Facebook, Netflix are Monday's stocks to watch 5:35 a.m. April 7, 2014 - Sue Chang
Facebook, Tesla slide into bear market territory 4:52 p.m. April 4, 2014 - Saumya Vaishampayan
Investors continue to pour out of biotech holdings 2:43 p.m. April 4, 2014 - Russ Britt
44 stocks on takeover target radar: Morgan Stanley 12:48 p.m. March 25, 2014 - blogs.marketwatch.com
U.S. stocks fall; Nasdaq skids 1.2% 4:40 p.m. March 24, 2014 - Anora Mahmudova
Apple gains on Comcast talk, new iPhone buzz 4:23 p.m. March 24, 2014 - Ben Eisen
First Solar, H-P, Symantec are stocks to watch 4:15 p.m. March 21, 2014 - Sue Chang
First Solar extends winning streak; Symantec plunges 3:06 p.m. March 21, 2014 - Ben Eisen
From every angle, technicals point to richer stocks 2:25 p.m. March 11, 2014 - The Trading Deck
U.S. stocks fall amid China worries 4:19 p.m. March 10, 2014 - Anora Mahmudova
Alexion rallies on upbeat outlook; Cliffs down on China 4:17 p.m. March 10, 2014 - Saumya Vaishampayan
Alexion bucks tide, gains on deal with France for blood disorder treatment 11:58 a.m. March 10, 2014 - blogs.marketwatch.com
Winning approval for new drugs may get harder, analyst warns 3:56 p.m. Feb. 28, 2014 - blogs.marketwatch.com
Yelp up on Yahoo deal; Apple gains as Icahn backs off 3:30 p.m. Feb. 10, 2014 - Saumya Vaishampayan
Corrective bounce, or viable market rally attempt? 11:34 a.m. Feb. 10, 2014 - Michael Ashbaugh
Utility stocks gain as Treasury yields lag 4:06 p.m. Feb. 4, 2014 - Wallace Witkowski
S&P 500 scores its best gain this year: stock market live blog recap 4:13 p.m. Jan. 30, 2014 - blogs.marketwatch.com
Facebook, Twitter highlight gainers; ADT unravels 3:55 p.m. Jan. 30, 2014 - Ben Eisen
Alexion shares leap on quarterly earnings, sunny forecast for 2014 10:56 a.m. Jan. 30, 2014 - blogs.marketwatch.com
Alexion Pharma shares surge 21%, S&P 500 best 9:43 a.m. Jan. 30, 2014 - Laura Mandaro
3 Top-Ranked Biotech Stocks on the Rebound - Analyst Blog 9:22 a.m. Today - Zacks.com
Nobody Expects a Spanish Disquistion 11:14 a.m. April 9, 2014 - Barrons.com
Alexion, Biogen Among Leading Big-Cap Biotechs 7:02 a.m. April 9, 2014 - Investors Business Daily
EPO Upholds Alnylam's McSwiggen Patent - Analyst Blog 7:00 p.m. April 8, 2014 - Zacks.com
Encouraging Pre-Clinical Data from Celldex - Analyst Blog 5:40 p.m. April 8, 2014 - Zacks.com
Intercept Pharma Prices 1M Share Offering, Shares Down - Analyst Blog 5:00 p.m. April 8, 2014 - Zacks.com
Pipeline Update from Idenix - Analyst Blog 4:55 p.m. April 8, 2014 - Zacks.com
A Sharp Pullback In Celldex Could Be A Window Of Opportunity 3:41 p.m. April 8, 2014 - Seeking Alpha
Halozyme Falls on Phase II Study Halt - Analyst Blog 12:10 p.m. April 8, 2014 - Zacks.com
Bristol-Myers Seeks FDA Approval for HCV Candidates - Analyst Blog 11:40 a.m. April 8, 2014 - Zacks.com
FDA Target Date for Gilead's HCV Candidate - Analyst Blog 11:30 a.m. April 8, 2014 - Zacks.com
RadNet Touches New 52-Week High - Analyst Blog 10:26 a.m. April 8, 2014 - Zacks.com
MannKind Slips on Afrezza Approval Delay - Analyst Blog 8:52 a.m. April 8, 2014 - Zacks.com
Idenix Pharmaceuticals (IDIX) Jumps: Stock Up 12.4% - Tale of the Tape 8:51 a.m. April 8, 2014 - Zacks.com
Puma Biotechnology (PBYI) in Focus: Stock Tumbles 18.3% - Tale of the Tape 8:45 a.m. April 8, 2014 - Zacks.com
Questcor Pharmaceuticals (QCOR) Shows Strength: Stock Surges 18.7% in Session - Tale of the Tape 8:44 a.m. April 8, 2014 - Zacks.com
Alexion Pharmaceuticals Inc. (ALXN): Today's Featured Drugs Winner 5:00 p.m. April 7, 2014 - TheStreet.com
Momentum Slide to Continue for Netflix, Facebook? - Analyst Blog 1:21 p.m. April 7, 2014 - Zacks.com
FDA News Lifts Dyax Slightly - Analyst Blog 11:30 a.m. April 7, 2014 - Zacks.com
Exact Sciences Corporation (EXAS) in Focus: Stock Up 5.73% - Tale of the Tape 8:44 a.m. April 7, 2014 - Zacks.com
Alexion Pharmaceuticals to Report First Quarter 2014 Results on Thursday, April 24, 2014 28 min ago - BusinessWire - BZX
BioMed Realty Invests In Life Science Research Facilities Leased To Yale University, Yale-New Haven Hospital And Alexion Pharmaceuticals 7:00 a.m. April 7, 2014 - PR Newswire - PRF
Study Results, Stock Price Movements, Product Launches, and Updates on Court Case Trials - Analyst Notes on Medtronic, Alexion, DaVita, Thermo Fisher Scientific, and Medicines 8:00 a.m. April 4, 2014 - PR Newswire - PRF
Drug Approvals, Stock Price Movements, and New Tools for Standardization - Analyst Notes on Biogen Idec, Alexion, Actavis, Thermo Fisher Scientific, and Medtronic 8:00 a.m. March 26, 2014 - PR Newswire - PRF
Pre-market Biotech Picks -- Research on Merrimack Pharma, Alexion Pharma, Incyte, and Aastrom Biosciences 11:25 a.m. March 25, 2014 - PR Newswire - PRF
Conference Schedules, Upcoming Marathon Applications, Revised Guidance, and Acquisitions - Analyst Notes on Celgene, Medtronic, Alexion, Quest Diagnostics, and Illumina 8:00 a.m. March 14, 2014 - PR Newswire - PRF
Alexion Revises Upward 2014 Financial Guidance for Revenues and non-GAAP EPS 6:31 a.m. March 10, 2014 - BusinessWire - BZX
Collaborations, Conferences, and Recognitions - Analyst Notes on Illumina, Alexion, Medtronic, Sirona, and NPS Pharmaceuticals 2:08 p.m. March 5, 2014 - PR Newswire - PRF
Alexion to Present at the Barclays Global Healthcare Conference 11:00 a.m. March 5, 2014 - BusinessWire - BZX
Critical Alerts For Baidu.com, Gilead Sciences, Deere, Alexion Pharmaceuticals, and Ford Released By InvestorsObserver 10:31 a.m. March 5, 2014 - PR Newswire - PRF
NICE Confirms AGNSS Positive Assessment that Eculizumab (Soliris®
is a Very Effective Treatment for aHUS Patients and Produces Substantial Quality-Adjusted Life Year Gains of a Magnitude Rarely Seen for a New Drug 8:02 p.m. March 3, 2014 - BusinessWire - BZX
Alexion Joins Patient Organizations Worldwide in Recognizing Rare Disease Day 2014 3:01 a.m. Feb. 28, 2014 - BusinessWire - BZX
Alexion to Present at the Cowen and Company 34th Annual Health Care Conference 11:01 a.m. Feb. 25, 2014 - BusinessWire - BZX
European Commission Grants Orphan Drug Designation to Soliris® (Eculizumab) for Prevention of Delayed Graft Function (DGF) after Solid Organ Transplantation 7:30 a.m. Feb. 24, 2014 - BusinessWire - BZX
Critical Alerts For Twitter, Alexion Pharmaceuticals, Pfizer, Ctrip, and AngloGold Ashanti Released By InvestorsObserver 10:31 a.m. Jan. 31, 2014 - PR Newswire - PRF
Alexion Reports Fourth Quarter and Full Year 2013 Results and Provides Financial Guidance for 2014 7:31 a.m. Jan. 30, 2014 - BusinessWire - BZX
FDA Grants Orphan Drug Designation to Soliris® (eculizumab) for Prevention of Delayed Graft Function (DGF) in Renal Transplant Patients 7:30 a.m. Jan. 21, 2014 - BusinessWire - BZX
Alexion Pharmaceuticals to Report Fourth Quarter and Full Year 2013 Results on Thursday, January 30, 2014 11:00 a.m. Jan. 16, 2014 - BusinessWire - BZX
Alexion Pharmaceuticals and Moderna Therapeutics Announce Exclusive Strategic Agreement to Develop Messenger RNA Therapeuticsâ?¢ for Rare Diseases 7:30 a.m. Jan. 13, 2014 - BusinessWire - BZX
Upcoming Presentations and Stock Price Movements - Research Report on Bard, Regeneron, Alexion, Seattle Genetics, and Isis Pharmaceuticals 9:00 a.m. Jan. 9, 2014 - PR Newswire
Tesla, Facebook, Netflix are Monday's stocks to watch 5:35 a.m. April 7, 2014 - Sue Chang
Facebook, Tesla slide into bear market territory 4:52 p.m. April 4, 2014 - Saumya Vaishampayan
Investors continue to pour out of biotech holdings 2:43 p.m. April 4, 2014 - Russ Britt
44 stocks on takeover target radar: Morgan Stanley 12:48 p.m. March 25, 2014 - blogs.marketwatch.com
U.S. stocks fall; Nasdaq skids 1.2% 4:40 p.m. March 24, 2014 - Anora Mahmudova
Apple gains on Comcast talk, new iPhone buzz 4:23 p.m. March 24, 2014 - Ben Eisen
First Solar, H-P, Symantec are stocks to watch 4:15 p.m. March 21, 2014 - Sue Chang
First Solar extends winning streak; Symantec plunges 3:06 p.m. March 21, 2014 - Ben Eisen
From every angle, technicals point to richer stocks 2:25 p.m. March 11, 2014 - The Trading Deck
U.S. stocks fall amid China worries 4:19 p.m. March 10, 2014 - Anora Mahmudova
Alexion rallies on upbeat outlook; Cliffs down on China 4:17 p.m. March 10, 2014 - Saumya Vaishampayan
Alexion bucks tide, gains on deal with France for blood disorder treatment 11:58 a.m. March 10, 2014 - blogs.marketwatch.com
Winning approval for new drugs may get harder, analyst warns 3:56 p.m. Feb. 28, 2014 - blogs.marketwatch.com
Yelp up on Yahoo deal; Apple gains as Icahn backs off 3:30 p.m. Feb. 10, 2014 - Saumya Vaishampayan
Corrective bounce, or viable market rally attempt? 11:34 a.m. Feb. 10, 2014 - Michael Ashbaugh
Utility stocks gain as Treasury yields lag 4:06 p.m. Feb. 4, 2014 - Wallace Witkowski
S&P 500 scores its best gain this year: stock market live blog recap 4:13 p.m. Jan. 30, 2014 - blogs.marketwatch.com
Facebook, Twitter highlight gainers; ADT unravels 3:55 p.m. Jan. 30, 2014 - Ben Eisen
Alexion shares leap on quarterly earnings, sunny forecast for 2014 10:56 a.m. Jan. 30, 2014 - blogs.marketwatch.com
Alexion Pharma shares surge 21%, S&P 500 best 9:43 a.m. Jan. 30, 2014 - Laura Mandaro
3 Top-Ranked Biotech Stocks on the Rebound - Analyst Blog 9:22 a.m. Today - Zacks.com
Nobody Expects a Spanish Disquistion 11:14 a.m. April 9, 2014 - Barrons.com
Alexion, Biogen Among Leading Big-Cap Biotechs 7:02 a.m. April 9, 2014 - Investors Business Daily
EPO Upholds Alnylam's McSwiggen Patent - Analyst Blog 7:00 p.m. April 8, 2014 - Zacks.com
Encouraging Pre-Clinical Data from Celldex - Analyst Blog 5:40 p.m. April 8, 2014 - Zacks.com
Intercept Pharma Prices 1M Share Offering, Shares Down - Analyst Blog 5:00 p.m. April 8, 2014 - Zacks.com
Pipeline Update from Idenix - Analyst Blog 4:55 p.m. April 8, 2014 - Zacks.com
A Sharp Pullback In Celldex Could Be A Window Of Opportunity 3:41 p.m. April 8, 2014 - Seeking Alpha
Halozyme Falls on Phase II Study Halt - Analyst Blog 12:10 p.m. April 8, 2014 - Zacks.com
Bristol-Myers Seeks FDA Approval for HCV Candidates - Analyst Blog 11:40 a.m. April 8, 2014 - Zacks.com
FDA Target Date for Gilead's HCV Candidate - Analyst Blog 11:30 a.m. April 8, 2014 - Zacks.com
RadNet Touches New 52-Week High - Analyst Blog 10:26 a.m. April 8, 2014 - Zacks.com
MannKind Slips on Afrezza Approval Delay - Analyst Blog 8:52 a.m. April 8, 2014 - Zacks.com
Idenix Pharmaceuticals (IDIX) Jumps: Stock Up 12.4% - Tale of the Tape 8:51 a.m. April 8, 2014 - Zacks.com
Puma Biotechnology (PBYI) in Focus: Stock Tumbles 18.3% - Tale of the Tape 8:45 a.m. April 8, 2014 - Zacks.com
Questcor Pharmaceuticals (QCOR) Shows Strength: Stock Surges 18.7% in Session - Tale of the Tape 8:44 a.m. April 8, 2014 - Zacks.com
Alexion Pharmaceuticals Inc. (ALXN): Today's Featured Drugs Winner 5:00 p.m. April 7, 2014 - TheStreet.com
Momentum Slide to Continue for Netflix, Facebook? - Analyst Blog 1:21 p.m. April 7, 2014 - Zacks.com
FDA News Lifts Dyax Slightly - Analyst Blog 11:30 a.m. April 7, 2014 - Zacks.com
Exact Sciences Corporation (EXAS) in Focus: Stock Up 5.73% - Tale of the Tape 8:44 a.m. April 7, 2014 - Zacks.com
Alexion Pharmaceuticals to Report First Quarter 2014 Results on Thursday, April 24, 2014 28 min ago - BusinessWire - BZX
BioMed Realty Invests In Life Science Research Facilities Leased To Yale University, Yale-New Haven Hospital And Alexion Pharmaceuticals 7:00 a.m. April 7, 2014 - PR Newswire - PRF
Study Results, Stock Price Movements, Product Launches, and Updates on Court Case Trials - Analyst Notes on Medtronic, Alexion, DaVita, Thermo Fisher Scientific, and Medicines 8:00 a.m. April 4, 2014 - PR Newswire - PRF
Drug Approvals, Stock Price Movements, and New Tools for Standardization - Analyst Notes on Biogen Idec, Alexion, Actavis, Thermo Fisher Scientific, and Medtronic 8:00 a.m. March 26, 2014 - PR Newswire - PRF
Pre-market Biotech Picks -- Research on Merrimack Pharma, Alexion Pharma, Incyte, and Aastrom Biosciences 11:25 a.m. March 25, 2014 - PR Newswire - PRF
Conference Schedules, Upcoming Marathon Applications, Revised Guidance, and Acquisitions - Analyst Notes on Celgene, Medtronic, Alexion, Quest Diagnostics, and Illumina 8:00 a.m. March 14, 2014 - PR Newswire - PRF
Alexion Revises Upward 2014 Financial Guidance for Revenues and non-GAAP EPS 6:31 a.m. March 10, 2014 - BusinessWire - BZX
Collaborations, Conferences, and Recognitions - Analyst Notes on Illumina, Alexion, Medtronic, Sirona, and NPS Pharmaceuticals 2:08 p.m. March 5, 2014 - PR Newswire - PRF
Alexion to Present at the Barclays Global Healthcare Conference 11:00 a.m. March 5, 2014 - BusinessWire - BZX
Critical Alerts For Baidu.com, Gilead Sciences, Deere, Alexion Pharmaceuticals, and Ford Released By InvestorsObserver 10:31 a.m. March 5, 2014 - PR Newswire - PRF
NICE Confirms AGNSS Positive Assessment that Eculizumab (Soliris®
is a Very Effective Treatment for aHUS Patients and Produces Substantial Quality-Adjusted Life Year Gains of a Magnitude Rarely Seen for a New Drug 8:02 p.m. March 3, 2014 - BusinessWire - BZX Alexion Joins Patient Organizations Worldwide in Recognizing Rare Disease Day 2014 3:01 a.m. Feb. 28, 2014 - BusinessWire - BZX
Alexion to Present at the Cowen and Company 34th Annual Health Care Conference 11:01 a.m. Feb. 25, 2014 - BusinessWire - BZX
European Commission Grants Orphan Drug Designation to Soliris® (Eculizumab) for Prevention of Delayed Graft Function (DGF) after Solid Organ Transplantation 7:30 a.m. Feb. 24, 2014 - BusinessWire - BZX
Critical Alerts For Twitter, Alexion Pharmaceuticals, Pfizer, Ctrip, and AngloGold Ashanti Released By InvestorsObserver 10:31 a.m. Jan. 31, 2014 - PR Newswire - PRF
Alexion Reports Fourth Quarter and Full Year 2013 Results and Provides Financial Guidance for 2014 7:31 a.m. Jan. 30, 2014 - BusinessWire - BZX
FDA Grants Orphan Drug Designation to Soliris® (eculizumab) for Prevention of Delayed Graft Function (DGF) in Renal Transplant Patients 7:30 a.m. Jan. 21, 2014 - BusinessWire - BZX
Alexion Pharmaceuticals to Report Fourth Quarter and Full Year 2013 Results on Thursday, January 30, 2014 11:00 a.m. Jan. 16, 2014 - BusinessWire - BZX
Alexion Pharmaceuticals and Moderna Therapeutics Announce Exclusive Strategic Agreement to Develop Messenger RNA Therapeuticsâ?¢ for Rare Diseases 7:30 a.m. Jan. 13, 2014 - BusinessWire - BZX
Upcoming Presentations and Stock Price Movements - Research Report on Bard, Regeneron, Alexion, Seattle Genetics, and Isis Pharmaceuticals 9:00 a.m. Jan. 9, 2014 - PR Newswire
(0)
(0)Scroll down for more posts ▼